Investigadors
-
Alejandro Fernández Simón
Digestiu
-
Alex Blasco
Digestiu
-
Alfredo Mata
Digestiu
Phd -
Anna Bargalló
Digestiu
Phd -
Carlos Hernández Ballesteros
Digestiu
-
Celia Vascónez Peña
Digestiu
-
David Barquero
Digestiu
-
Eva Erice
Digestiu
Phd -
Marta Martín Llahí
Digestiu
Phd -
Mercè Navarro
Digestiu
-
Orlando García Bosch
Digestiu
Phd -
Xavier Ariza
Digestiu
Phd
Contacteu amb el grup
Formulari-
Barquero D, González V, García O, Fernández A, Blasco A, Navarro M, Bargalló A, Martín M, Erice E, Ariza X, Hernández C, Vascónez C, Martín-Baranera M, Castellví J, Mata A. 326/20
Ways to perform an endoscopic tattoo. prospective and randomized study in patients with colorectal neoplasm.
Rev Esp Enferm Dig. 2020 Dec 1.
-
Cañete F, Mañosa M, Casanova MJ, González-Sueyro RC, Barrio J, Bermejo F, Nos P, Iglesias-Flores E, García-Planella E, Pérez-Calle JL, Vicente R, Vera M, Ramos L, Rivero M, De Francisco R, Montserrat A, Benítez O, Navarro P, Taxonera C, Hinojosa E, Márquez-Mosquera L, Navarro-Llavat M, Ramírez-de la Piscina P, Gomollón F, Rodríguez-Alonso L, Núñez-Alonso A, Fernández-Salazar L, Almela P, Ríos León R, De Castro L, Gisbert JP, Ricart E, Cabré E, Domènech E; ENEIDA registry by GETECCU. 175/19
Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Inflamm Bowel Dis. 2019;25(11):1862-1870.
-
Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group. (Navarro-Llavat M) 177/19
Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Aliment Pharmacol Ther. 2019;49(4):419-428.
-
Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU. (Navarro-Llavat M). 174/19
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034.
-
Repici A, Coron E, Sharma P, Spada C, Di Leo M, Noble CL, Gschossmann J, Bargalló García A, Baumgart DC. 179/19
Improved high-quality colon cleansing with 1L NER1006 versus 2L polyethylene glycol plus ascorbate or oral sulfate solution.
Dig Liver Dis. 2019;51(12):1671-1677.
-
Calafat M, Mañosa M, Cañete F, Ricart E, Iglesias E, Calvo M, Rodríguez-Moranta F, Taxonera C, Nos P, Mesonero F, Martín-Arranz MD, Mínguez M, Gisbert JP, García-López S, de Francisco R, Gomollón F, Calvet X, Garcia-Planella E, Rivero M, Martínez-Cadilla J, Argüelles F, Arias L, Cimavilla M, Zabana Y, Domènech E; ENEIDA registry of GETECCU. (Garcia-Bosch O) 178/19
Increased risk of thiopurine-related adverse events in elderly patients with IBD.
Aliment Pharmacol Ther. 2019;50(7):780-788.
-
Chavarría C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L, Rivero M, Argüelles-Arias F, Martín-Arranz MD, Martínez-Montiel MP, Valls M, Ferreiro-Iglesias R, Llaó J, Moraleja-Yudego I, Casellas F, Antolín-Melero B, Cortés X, Plaza R, Pineda JR, Navarro-Llavat M, García-López S, Robledo-Andrés P, Marín-Jiménez I, García-Sánchez V, Merino O, Algaba A, Arribas-López MR, Banales JM, Castro B, Castro-Laria L, Honrubia R, Almela P, Gisbert JP. 176/19
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study
J Crohns Colitis. 2019;13(8):996-1002.
-
Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P; GETECCU Group (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa). (Navarro-Llavat M). 179/19
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry.
Aliment Pharmacol Ther. 2019;50(3):278-288.
-
Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group. (Navarro-Llavat M) 69/18
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther. 2018;48(8):839-851.
-
Lopez-Doriga A, Valle L, Alonso MH, Aussó S, Closa A, Sanjuan X, Barquero D, Rodríguez-Moranta F, Sanz-Pamplona R, Moreno V. 18/18
Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.
Biochim Biophys Acta Mol Basis Dis. 2018;1864(9 Pt B):2992-3000.
Projectes
-
Digestiu
Investigador
- Any 2019
- Hospital de Sant Joan Despí Moisès Broggi
Endoscopia versus tratamiento quirúrgico para el tratamiento de los cánceres colorectales pT1: Estudio de cohortes de base poblacional - EpiT1.
-
PROMOTOR:
Dra. María Pellisé Urquiza. Hospital Clínic de Barcelona
-
TIPUS E:
PI
- Any 2019
- Sant Joan Despí Moisès Broggi Hospital
Protocol for the detection of previously unknown liver disease in hospitalized patients with alcohol use disorder.
-
PROMOTOR:
Marta Martin
-
TIPUS E:
PINE TREE
- Any 2019
- Sant Joan Despí Moisès Broggi Hospital
Effectiveness and tolerability of ustekinumab in clinical practice in patients with active Crohn's disease
-
PROMOTOR:
Janssen Cilag, Spain
-
TIPUS E:
EPA-OD
- Any 2019
- Sant Joan Despí Moisès Broggi Hospital
Endoscopy versus surgical treatment for the treatment of pT1 colorectal cancers: Study of population-based cohorts - EpiT1.
-
PROMOTOR:
Dr. María Pellisé Urquiza. Clinical Hospital of Barcelona
-
TIPUS E:
PINE TREE
- Any 2019
- Sant Joan Despí Moisès Broggi Hospital
Albumin for the management of hypervolemic hyponatremia in patients with decompensated cirrhosis. Concept study.
-
PROMOTOR:
Clinical Foundation for Biomedical Research
-
TIPUS E:
RD2015
- Any 2019
- Sant Joan Despí Moisès Broggi Hospital
Study of the clinical and virological factors associated with virological control after withdrawal of antiviral treatment in patients with HBeAg-negative chronic hepatitis.
-
PROMOTOR:
Clinical Foundation for Biomedical Research
-
TIPUS E:
PINE TREE
Digestiu
Investigador
- Any 2018
- Hospital de Sant Joan Despí Moisès Broggi
Estudio multicentrico, prospectivo de la resección endoscópica transmural en colon utilizando Over-the-Scope-Clip (OTSC),
-
PROMOTOR:
Hospital Univeristari de Girona Doctor Josep Trueta
-
TIPUS E:
PI
Digestiu
Investigador
- Any 2018
- Hospital de Sant Joan Despí Moisès Broggi
Riesgo de insuficiencia suprarenal e impacto en la calidad de vida del tratamiento con esteroides convencionales en la enfermedad inflamatoria crónica intestinal,
-
PROMOTOR:
Mercè Navarro Llavat
-
TIPUS E:
PI
Digestiu
Investigador
- Any 2018
- Hospital de Sant Joan Despí Moisès Broggi
Resultados de vedolizumab y anti-TNFs en pacientes con colitis ulcerosa y enfermedad de Crohn tratados en la práctica clínica real (EVOLVE) – IBERIA,
-
PROMOTOR:
Takeda Farmacéutica España SA
-
TIPUS E:
EPA
Línies d’actuació- Digestive Endoscopy
- Inflammatory Bowel Disease
Documents
Informació d’interès
Enllaços
